Travere Therapeutics, Inc.
SEC Filing List
TVTX CIK: 0001438533
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Baynes Roy D. | Travere Therapeutics, Inc. | 04/07/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Travere Therapeutics, Inc. | 04/06/2026 | ||
| ARS | Annual report to security holders | Travere Therapeutics, Inc. | 04/06/2026 | ||
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 04/06/2026 | ||
| DEF 14A | Definitive proxy statements | Travere Therapeutics, Inc. | 04/06/2026 | ||
| 4 | Statement of changes in beneficial owner... | Reed Elizabeth E | Travere Therapeutics, Inc. | 04/02/2026 | |
| 4 | Statement of changes in beneficial owner... | Dube Eric M | Travere Therapeutics, Inc. | 04/02/2026 | |
| 144 | Filing for proposed sale of securities u... | Fidelity Brokerage Services LLC/FA | 04/01/2026 | ||
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 04/01/2026 | ||
| SCHEDULE 13G/A | 03/27/2026 | ||||
| No record found. | |||||
| Load More | |||||
